Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080745443> ?p ?o ?g. }
- W3080745443 endingPage "112752" @default.
- W3080745443 startingPage "112752" @default.
- W3080745443 abstract "Novel 2-indolinone thiazole hybrids were designed and synthesized as VEGFR-2 inhibitors based on sunitinib, an FDA-approved anticancer drug. The proposed structures of the prepared 2-indolinone thiazole hybrids were confirmed based on their spectral data and CHN analyses. The target compounds were screened in vitro for their anti-VEGFR-2 activity. All tested compounds exhibited a potent submicromolar inhibition of VEGFR-2 kinase with IC50 values ranging from 0.067 to 0.422 μM, relative to sunitinib reference drug (IC50 = 0.075 ± 0.002 μM). Compounds 5, 15a, 15b, 17, 19c displayed excellent VEGFR-2 inhibitory activity, comparable or nearly equipotent to sunitinib. Compound 13b stood out as the most potent against VEGFR-2 showing IC50 value of 0.067 ± 0.002 μM, lower than that of sunitinib. In addition, the most potent derivatives were assessed for their anticancer activity against two renal cancer cell lines. Compound 13b (IC50 = 3.9 ± 0.13 μM) was more potent than sunitinib (IC50 = 4.93 ± 0.16 μM) against CAKI-1 cell line. Moreover, thiazole 15b displayed excellent anticancer activity against CAKI-1 cell line (IC50 = 3.31 ± 0.11 μM), superior to that of sunitinib (IC50 = 4.93 ± 0.16 μM). Thiazole 15b was also equipotent to sunitinib (IC50 = 1.23 ± 0.04 μM) against A498 cell line. Besides, compound 15b revealed a safety profile much better than that of sunitinib against normal human renal cells. Furthermore, a docking study revealed a proper fitting of the most active compounds into the ATP binding site of VEGFR-2, rationalizing their potent anti-VEGFR-2 activity." @default.
- W3080745443 created "2020-09-01" @default.
- W3080745443 creator A5041779333 @default.
- W3080745443 creator A5069401469 @default.
- W3080745443 creator A5072430012 @default.
- W3080745443 creator A5075755375 @default.
- W3080745443 creator A5087324539 @default.
- W3080745443 date "2020-12-01" @default.
- W3080745443 modified "2023-10-02" @default.
- W3080745443 title "Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity" @default.
- W3080745443 cites W1573363574 @default.
- W3080745443 cites W1891334654 @default.
- W3080745443 cites W1967062678 @default.
- W3080745443 cites W1972739162 @default.
- W3080745443 cites W1973852135 @default.
- W3080745443 cites W2009968499 @default.
- W3080745443 cites W2063544208 @default.
- W3080745443 cites W2064360454 @default.
- W3080745443 cites W2067216473 @default.
- W3080745443 cites W2113595687 @default.
- W3080745443 cites W2114918609 @default.
- W3080745443 cites W2142656868 @default.
- W3080745443 cites W2144441413 @default.
- W3080745443 cites W2144707486 @default.
- W3080745443 cites W2147328441 @default.
- W3080745443 cites W2150048971 @default.
- W3080745443 cites W2153331460 @default.
- W3080745443 cites W2166573361 @default.
- W3080745443 cites W2173189766 @default.
- W3080745443 cites W2286433349 @default.
- W3080745443 cites W2330896126 @default.
- W3080745443 cites W2564638997 @default.
- W3080745443 cites W2565408756 @default.
- W3080745443 cites W2766248755 @default.
- W3080745443 cites W2773721806 @default.
- W3080745443 cites W2781631523 @default.
- W3080745443 cites W2804842145 @default.
- W3080745443 cites W2884186513 @default.
- W3080745443 cites W2887073112 @default.
- W3080745443 cites W2890352215 @default.
- W3080745443 cites W2898829340 @default.
- W3080745443 cites W2900605906 @default.
- W3080745443 cites W2916321864 @default.
- W3080745443 cites W2982719962 @default.
- W3080745443 cites W2995463243 @default.
- W3080745443 cites W2999417355 @default.
- W3080745443 cites W3011543462 @default.
- W3080745443 cites W349597153 @default.
- W3080745443 cites W4367038403 @default.
- W3080745443 doi "https://doi.org/10.1016/j.ejmech.2020.112752" @default.
- W3080745443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32947227" @default.
- W3080745443 hasPublicationYear "2020" @default.
- W3080745443 type Work @default.
- W3080745443 sameAs 3080745443 @default.
- W3080745443 citedByCount "44" @default.
- W3080745443 countsByYear W30807454432020 @default.
- W3080745443 countsByYear W30807454432021 @default.
- W3080745443 countsByYear W30807454432022 @default.
- W3080745443 countsByYear W30807454432023 @default.
- W3080745443 crossrefType "journal-article" @default.
- W3080745443 hasAuthorship W3080745443A5041779333 @default.
- W3080745443 hasAuthorship W3080745443A5069401469 @default.
- W3080745443 hasAuthorship W3080745443A5072430012 @default.
- W3080745443 hasAuthorship W3080745443A5075755375 @default.
- W3080745443 hasAuthorship W3080745443A5087324539 @default.
- W3080745443 hasConcept C121608353 @default.
- W3080745443 hasConcept C126322002 @default.
- W3080745443 hasConcept C159110408 @default.
- W3080745443 hasConcept C185592680 @default.
- W3080745443 hasConcept C202751555 @default.
- W3080745443 hasConcept C2777752497 @default.
- W3080745443 hasConcept C2778464347 @default.
- W3080745443 hasConcept C2779490328 @default.
- W3080745443 hasConcept C41685203 @default.
- W3080745443 hasConcept C54355233 @default.
- W3080745443 hasConcept C55493867 @default.
- W3080745443 hasConcept C71240020 @default.
- W3080745443 hasConcept C71924100 @default.
- W3080745443 hasConcept C81885089 @default.
- W3080745443 hasConcept C86803240 @default.
- W3080745443 hasConcept C98274493 @default.
- W3080745443 hasConceptScore W3080745443C121608353 @default.
- W3080745443 hasConceptScore W3080745443C126322002 @default.
- W3080745443 hasConceptScore W3080745443C159110408 @default.
- W3080745443 hasConceptScore W3080745443C185592680 @default.
- W3080745443 hasConceptScore W3080745443C202751555 @default.
- W3080745443 hasConceptScore W3080745443C2777752497 @default.
- W3080745443 hasConceptScore W3080745443C2778464347 @default.
- W3080745443 hasConceptScore W3080745443C2779490328 @default.
- W3080745443 hasConceptScore W3080745443C41685203 @default.
- W3080745443 hasConceptScore W3080745443C54355233 @default.
- W3080745443 hasConceptScore W3080745443C55493867 @default.
- W3080745443 hasConceptScore W3080745443C71240020 @default.
- W3080745443 hasConceptScore W3080745443C71924100 @default.
- W3080745443 hasConceptScore W3080745443C81885089 @default.
- W3080745443 hasConceptScore W3080745443C86803240 @default.
- W3080745443 hasConceptScore W3080745443C98274493 @default.
- W3080745443 hasLocation W30807454431 @default.